Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Open Forum Infectious Diseases|January 31, 2019
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple SclerosisMaria R Ciardi, Marco Iannetta, Maria A Zingaropoli, et al.Journal of Neurovirology|May 2, 2015
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatmentValeria Pietropaolo, Anna Bellizzi, Elena Anzivino, et al.Journal of Neuroinflammation|September 2, 2024
Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity-associated EAAT2Antonella D'Ambrosio, Silvia Zamboni, Serena Camerini, et al.Scientific Reports|January 24, 2019
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patientsMarco Iannetta, Maria Antonella Zingaropoli, Tiziana Latronico, et al.European Neurology|February 1, 2014
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter studyLuca Prosperini, Chiara Rosa Mancinelli, Carlo Pozzilli, et al.Virology Journal|October 2, 2013
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational studyAnna Bellizzi, Elena Anzivino, Donatella Maria Rodio, et al.Plos One|August 4, 2016
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV ReactivationMarco Iannetta, Maria Antonella Zingaropoli, Anna Bellizzi, et al.Biomed Research International|April 24, 2018
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus SerostatusMaria A Zingaropoli, Marco Iannetta, Simona Pontecorvo, et al.Journal of Neurology|November 24, 2016
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosisLuca Prosperini, Francesco Saccà, Cinzia Cordioli, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 5, 2018
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosisDoriana Landi, Paolo Ragonese, Luca Prosperini, et al.Pageof 3